Full Name
Alan Prem Kumar
Variants
Kumar, A.P.
Kumar, A.
Prem Kumar, A.
Kumar, Alan Prem Rem
 
 
 
Email
apkumar@nus.edu.sg
 
Other emails
 

Publications

Results 1-20 of 59 (Search time: 0.012 seconds).

Issue DateTitleAuthor(s)
12017Wnt signaling in triple-negative breast cancerPohl, Sö.-G; Brook, N; Agostino, M; Arfuso, F; Kumar, A.P ; Dharmarajan, A
21-Jun-2013Ursolic acid in cancer prevention and treatment: Molecular targets, pharmacokinetics and clinical studiesShanmugam, M.K. ; Dai, X.; Kumar, A.P. ; Tan, B.K.H.; Sethi, G.; Bishayee, A.
32018TIPE family of proteins and its implications in different chronic diseasesBordoloi D.; Banik K.; Shabnam B.; Padmavathi G.; Monisha J.; Arfuso F.; Dharmarajan A.; Mao X., Lim L.H.K. ; Wang L. ; Fan L. ; Hui K.M. ; Kumar A.P. ; Sethi G. ; Kunnumakkara A.B.
415-Feb-2012Thymoquinone: Potential cure for inflammatory disorders and cancerWoo, C.C.; Kumar, A.P. ; Sethi, G.; Tan, K.H.B.
52018The role of signal transducer and activator of transcription 3 (STAT3) and its targeted inhibition in hematological malignanciesArora, L; Kumar, A.P ; Arfuso, F; Chng, W.J ; Sethi, G 
62017The role of resveratrol in cancer therapyKo, J.-H; Sethi, G ; Um, J.-Y; Shanmugam, M.K ; Arfuso, F; Kumar, A.P ; Bishayee, A; Ahn, K.S
72015The multifaceted role of curcumin in cancer prevention and treatmentShanmugam M.K; Rane G; Kanchi M.M; Arfuso F; Chinnathambi A; Zayed M.E; Alharbi S.A; Tan B.K.H ; ALAN PREM KUMAR ; Sethi G 
82-Mar-2022The long and short non-coding RNAs modulating EZH2 signaling in cancerMirzaei, Sepideh; Gholami, Mohammad Hossein; Hushmandi, Kiavash; Hshemi, Farid; Zabolian, Amirhossein; Canadas, Israel; Zarrabi, Ali; Nabavi, Noushin; Aref, Amir Reza; Crea, Francesco; Wang, Yuzhuo; Ashrafizadeh, Milad; Kumar, Alan Prem 
9Apr-2014Targeting the STAT3 signaling pathway in cancer: Role of synthetic and natural inhibitorsSikka, S.; Surana, R.; Dai, X.; Zhang, J.; Kumar, A.P. ; Tan, B.K.H.; Sethi, G.; Bishayee, A.
102012Targeting PPAR γ signaling cascade for the prevention and treatment of prostate cancerSikka, S.; Chen, L.; Sethi, G.; Kumar, A.P. 
111-May-2022Targeting Nuclear Receptors in Lung Cancer-Novel Therapeutic ProspectsGangwar, Shailendra Kumar; Kumar, Aviral; Yap, Kenneth Chun-Hong ; Jose, Sandra; Parama, Dey; Sethi, Gautam ; Kumar, Alan Prem ; Kunnumakkara, Ajaikumar B
1215-Apr-2019Targeting autophagy using natural compounds for cancer prevention and therapyDeng, Shuo ; Shanmugam, Muthu K ; Kumar, Alan Prem ; Yap, Celestial T ; Sethi, Gautam ; Bishayee, Anupam
131-Dec-2022Targeting autophagy in prostate cancer: preclinical and clinical evidence for therapeutic responseAshrafizadeh, M; Paskeh, MDA; Mirzaei, S; Gholami, MH; Zarrabi, A; Hashemi, F; Hushmandi, K; Hashemi, M; Nabavi, N; Crea, F; Ren, J; Klionsky, DJ; Kumar, AP ; Wang, Y
1428-Jul-2012Targeted inhibition of tumor proliferation, survival, and metastasis by pentacyclic triterpenoids: Potential role in prevention and therapy of cancerShanmugam, M.K. ; Nguyen, A.H.; Kumar, A.P. ; Tan, B.K.H.; Sethi, G.
151-Dec-2013Targeted abrogation of diverse signal transduction cascades by emodin for the treatment of inflammatory disorders and cancerShrimali, D.; Shanmugam, M.K. ; Kumar, A.P. ; Zhang, J.; Tan, B.K.H.; Ahn, K.S.; Sethi, G.
162017SREBP-1c as a molecular bridge between lipogenesis and cell cycle progression of clear cell renal carcinomaSethi, G ; Shanmugam, M.K ; Kumar, A.P 
1718-Feb-2021Small in size, but large in action: Micrornas as potential modulators of pten in breast and lung cancersAbadi, Asal Jalal; Zarrabi, Ali; Gholami, Mohammad Hossein; Mirzaei, Sepideh; Hashemi, Farid; Zabolian, Amirhossein; Entezari, Maliheh; Hushmandi, Kiavash; Ashrafizadeh, Milad; Khan, Haroon; Kumar, Alan Prem 
18Dec-2013Secreted frizzled related proteins: Implications in cancersSurana, R.; Sikka, S.; Cai, W.; Shin, E.M.; Warrier, S.R.; Tan, H.J.G.; Arfuso, F.; Fox, S.A.; Dharmarajan, A.M.; Kumar, A.P. 
192018Role of RNF20 in cancer development and progression – a comprehensive reviewSethi, G ; Shanmugam, M.K ; Arfuso, F; Kumar, A.P 
202018Role of novel histone modifications in cancerShanmugam, M.K ; Arfuso, F; Arumugam, S; Chinnathambi, A; Jinsong, B ; Warrier, S; Wang, L.Z ; Kumar, A.P ; Ahn, K.S; Sethi, G ; Lakshmanan, M